Company Filing History:
1 out of 3,539 
1 out of 11 
1 out of 38 
Years Active: 2016
Title: Stephanie Federico: Innovator in Fluorescent Antagonists
Introduction
Stephanie Federico is a notable inventor based in Trieste, Italy. She has made significant contributions to the field of pharmacology, particularly through her innovative work on fluorescent antagonists of the A3 adenosine receptor. Her research has implications for diagnostic methods and potential treatments involving these compounds.
Latest Patents
Stephanie Federico holds a patent for "Fluorescent antagonists of the A3 adenosine receptor." This patent discloses compounds that are fluorescently labeled antagonists of the adenosine receptor. The compounds are described by a specific formula, where A, R, R, and Y are defined in the patent documentation. Additionally, the patent outlines diagnostic compositions and methods for diagnosing patients for possible treatments using these antagonists.
Career Highlights
Throughout her career, Stephanie has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Università Degli Studi di Trieste. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Stephanie has collaborated with esteemed colleagues, including Kenneth Alan Jacobson and Santhosh Kumar Thatikonda. These collaborations have enriched her research and expanded the impact of her work in the field.
Conclusion
Stephanie Federico is a pioneering inventor whose work on fluorescent antagonists has the potential to enhance diagnostic methods and treatment options. Her contributions to pharmacology and her collaborations with other experts highlight her significant role in advancing medical science.